CONTACT US   |  (864) 397-5101

DPX Technologies Unveils a New Brand, Website

Columbia, SC – DPX Technologies, a manufacturer of laboratory consumable products, announces the launch of a new brand image. DPX has been manufacturing pipette tips for sample preparation since 2007. Their patented technologies are available across the U.S., and DPX plans to increase sales internationally.

The rebrand includes a new company logo, website and other marketing collateral. DPX also updated the product lines with a trademark for the name INTip™. Product lines include INTip™ Solid Phase Extraction and INTip™ Filtration. This strategic brand update aligns product segments within different industries and highlights pipette tip technology for sample preparation.

The future of DPX lies in the proteomics and genomics industries. Dr. Brewer sees a big future with INTip products for protein purification and DNA purification. “INTip compliments the existing core technology and delivers the new brand expansion for pipette tip products in market segments where automated sample preparation is highly sought after,” said Dr. Brewer, founder and CEO of DPX Technologies. “Pipette tips are easy to use and easy to automate, which will increase efficiency, robustness and reproducibility for protein purification and DNA purification.”

DPX products are currently sold across the U.S., Canada and in Brazil. “We are starting to pick up leads in Europe, Australia and China. We are excited about expanding our product offerings internationally,” said Bill Kemnitzer, PhD., Director of Sales and Business Development.

# # #

About DPX Technologies

DPX is committed to providing innovative sample purification solutions. We collaborate with our customers to provide the high-quality products they need for complex chemical and biological analysis.  Visit them at https://dpxtechnologies.com/

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.